The best way to get off Suboxone is a slow, gradual taper — usually small dose reductions every 2–4 weeks, with the slowest reductions at the end. There is no single timeline that fits everyone. Many patients do better staying on Suboxone long-term than tapering off, because stopping is associated with return to opioid use and increased overdose risk. Talk with your clinician about whether tapering is the right goal for you, and never taper without medical support.
Should you try to get off Suboxone at all?
This is the most important question, and it is often skipped. The evidence strongly supports buprenorphine as one of the most effective treatments for opioid use disorder, and many patients benefit from long-term or indefinite treatment. SAMHSA, ASAM, and NIDA all support long-term treatment as appropriate for many patients.
The framing that the “goal” is to get off Suboxone comes more from stigma than from medical evidence. People with diabetes are not pressured to get off insulin. People with high blood pressure are not pressured to get off lisinopril. Buprenorphine treats a chronic medical condition, and stopping it can carry real risk — including return to use, overdose, and death.
If you are stable, functioning, free from cravings, and not having side effects that bother you, continuing your daily dose may be the safest choice. Wanting to be off the medication is a valid feeling, and it deserves a real conversation with a clinician — not a quick taper.
When is tapering reasonable?
Tapering can be reasonable when several conditions are present at the same time. There is no fixed checklist, but clinicians often look for:
- You have been stable on Suboxone for a meaningful period — often a year or longer, though there is no magic number.
- Your life circumstances are stable — housing, work, relationships, mental health.
- You are not in early recovery from a recent return to use.
- You have a strong support system and a plan to prevent return to use.
- Your clinician agrees the timing is right.
- You understand that you can restart Suboxone at any time without judgment, and that returning to it is a medical decision, not a failure.
Pregnancy, active major life stress, recent return to use, and uncontrolled mental health conditions are usually reasons to delay a taper.
What does a slow Suboxone taper look like?
There is no single “best” tapering schedule, but most clinicians use small dose reductions spaced weeks apart. A common framework looks something like this:
| Dose range | Typical reduction | Time between reductions |
|---|---|---|
| 16–24 mg | 2–4 mg at a time | 2–4 weeks |
| 8–16 mg | 2 mg at a time | 2–4 weeks |
| 4–8 mg | 1–2 mg at a time | 3–6 weeks |
| 2–4 mg | 0.5–1 mg at a time | 4–8 weeks |
| Below 2 mg | 0.25–0.5 mg at a time | 4–8 weeks or longer |
This is an example of how clinicians sometimes think about taper speed. It is not a prescription, not a standard protocol, and not appropriate for every patient. Many patients need slower schedules — especially in the lower-dose range, where withdrawal symptoms are often most noticeable. The lowest doses are usually the hardest part of the taper. Going more slowly here is not a failure; it is good clinical practice.
Why is a slow taper better than a fast one?
Two main reasons.
Withdrawal severity. Slow tapers give the brain time to adjust to lower opioid receptor activation. Fast tapers cause more intense withdrawal symptoms — muscle aches, anxiety, insomnia, restlessness, GI upset — which is uncomfortable and increases the risk of stopping early or returning to use.
Outcomes. Studies have generally shown that longer tapers and longer overall treatment durations are associated with better outcomes. Rapid tapers, particularly in the first year of treatment, are linked to high rates of return to opioid use. The NIDA-supported research on extended buprenorphine treatment supports continuing treatment for as long as it is helping.
How does Sublocade fit into a taper?
Sublocade is the monthly extended-release injection of buprenorphine. Some clinicians use Sublocade as part of a taper strategy because medication levels decline gradually after the last injection. This can feel like a built-in taper for some patients, but it is not a universal taper solution. Per the FDA-approved label, after steady state, patients discontinuing Sublocade may have detectable plasma and urine buprenorphine levels for 12 months or longer.
This can be useful for people who struggle with daily dosing or who want a more passive taper experience. Sublocade has a REMS (Risk Evaluation and Mitigation Strategy) and a boxed warning for serious harm if injected intravenously, so it is administered only by a healthcare provider in a certified setting. Whether Sublocade is right for your taper is a clinical decision — talk with your physician.
What are common withdrawal symptoms during a taper?
Even with a slow taper, many people notice some symptoms when reducing dose. Most commonly:
- Mild muscle aches or restlessness
- Sleep changes — trouble falling asleep, vivid dreams
- Increased anxiety or low mood
- Mild GI upset
- Sweating, runny nose, or watery eyes
- Yawning or fatigue
These symptoms are usually mildest when the taper is slow and most noticeable in the first 1–2 weeks after a dose reduction. If symptoms are significant, the answer is usually not to push through but to slow down: hold the current dose longer, go back to the previous dose, or extend the time between reductions.
What if I have cravings during a taper?
Returning cravings during a taper are an important warning sign. They mean the dose reduction may be too fast, or that this may not be the right time to taper. Cravings are a clinical signal, not a personal failure. The right response is to talk with your clinician — not to push forward.
Options when cravings return during a taper:
- Pause the taper and stay at the current dose
- Return to a previous, higher dose where cravings were absent
- Reassess whether tapering is the right goal right now
- Add or strengthen non-medication supports (counseling, peer support, therapy)
What if I return to opioid use during or after a taper?
Returning to use after stopping or tapering is common. It is not a moral failure, and it is not a sign that buprenorphine “didn’t work” — it is a sign that the chronic condition needs ongoing treatment.
The most important thing if you return to use, especially in the current fentanyl-dominant drug supply: tolerance drops quickly after stopping opioids, which means overdose risk is much higher than before treatment. Carry naloxone (Narcan), tell people you trust, never use alone, and contact your clinician as soon as possible to restart treatment.
Restarting buprenorphine is often very possible, but it should be done with clinical guidance. If fentanyl, methadone, long-acting opioids, or heavy opioid use are involved, induction timing can be more complicated because of precipitated withdrawal risk. Your clinician can guide this.
How long does a Suboxone taper usually take?
Tapers vary widely. Some patients complete a taper in 3–6 months. Others take a year or longer. Some begin a taper, find that they prefer staying on the medication, and stop tapering — that is also a valid outcome. The goal is the best long-term outcome, not the fastest exit.
Rapid tapers (a few weeks or less) are generally not recommended outside of specific clinical situations and are associated with worse outcomes.
What about “getting off” without tapering — cold turkey?
Stopping Suboxone abruptly causes withdrawal symptoms that can last several weeks — longer than withdrawal from short-acting opioids because of buprenorphine’s long half-life. Cold-turkey stopping is associated with high rates of return to use and is not the recommended approach. If you have stopped suddenly and are in withdrawal, contact a clinician — restarting buprenorphine is straightforward and safe.
Is long-term Suboxone treatment safe?
Long-term buprenorphine treatment is appropriate for many patients and may continue indefinitely when benefits outweigh risks. Long-term considerations include dental problems with medicines dissolved in the mouth (rinse with water and wait before brushing), constipation, sedation or interactions with other CNS depressants, liver monitoring in selected patients, and possible hormone or fertility effects in some patients. None of these are reasons to taper unnecessarily — they are reasons to talk with your clinician about management.
For many patients, ongoing daily Suboxone is the safest, most stable, and most evidence-based path. There is no medical reason to taper just because time has passed.
